Cell senescence gene database Home
Cell senescence database
General information | Literature | Expression | Regulation | Mutation | Homolog | Interaction

Basic Information

Gene ID

183

Name

AGT

Synonym

ANHU|SERPINA8;angiotensinogen (serpin peptidase inhibitor, clade A, member 8);AGT;angiotensinogen (serpin peptidase inhibitor, clade A, member 8)

Definition

alpha-1 antiproteinase, antitrypsin|angiotensin I|angiotensin II|angiotensinogen|pre-angiotensinogen|serine (or cysteine) proteinase inhibitor|serpin A8

Position

1q42.2

Gene Type

protein-coding

Pathways and Diseases

Pathway

bioactive peptide induced signaling pathway;PID BioCarta;100226

Pathway

Peptide ligand-binding receptors;PID Reactome;500405

Pathway

Signaling by GPCR;Reactome;REACT:14797

Pathway

AP-1 transcription factor network;PID Curated;200118

Pathway

Renin-angiotensin system;KEGG PATHWAY;hsa04614

Pathway

angiotensin ii mediated activation of jnk pathway via pyk2 dependent signaling;PID BioCarta;100236

Pathway

role of egf receptor transactivation by gpcrs in cardiac hypertrophy;PID BioCarta;100221

Pathway

Signaling events mediated by PRL;PID Curated;200006

Pathway

Metabolism of lipids and lipoproteins;Reactome;REACT:22258

Disease

Preeclampsia, susceptibility to;OMIM

Disease

Lupus erythematosus;FunDO

Disease

Adenocarcinoma;FunDO

Disease

serum concentrations of creatinine;GAD

Disease

insulin response to oral glucose;GAD

Disease

Renal tubular dysgenesis;OMIM

Disease

Cardiovascular disease;FunDO

Disease

cardiovascular;GAD

Disease

Erythropoietin Induced Hypertension;GAD

Disease

Myocardial Ischemia;GAD

Disease

Hyperglycemia;FunDO

Disease

Hypertension, essential, susceptibility to;OMIM

Disease

Albuminuria;GAD

Disease

Intermediate coronary syndrome;FunDO

Disease

obesity;GAD

Disease

Vascular dementia;FunDO

Disease

PSYCH;GAD

Disease

Henoch-Schoenlein purpura;FunDO

Disease

Stomach cancer;FunDO

Disease

Depression;FunDO

Disease

sleep apnea;GAD

Disease

Essential Hypertension;GAD

Disease

Esotropia;FunDO

Disease

Hypercholesterolemia;FunDO

Disease

restenosis after percutaneous transluminal coronary angioplasty;GAD

Disease

Embryoma;FunDO

Disease

AGING;GAD

Disease

hypertension;GAD

Disease

diabetes, type 1;GAD

Disease

familial hypertension of early onset.;GAD

Disease

Chronic rejection of renal transplant;FunDO

Disease

atherosclerosis, coronary;GAD

Disease

IMMUNE;GAD

Disease

Mouth Neoplasms;GAD

Disease

renal disease, end stage;GAD

Disease

cardiovascular disease;GAD

Disease

PHARMACOGENOMIC;GAD

Disease

Carcinoma, Squamous Cell;GAD

Disease

blood pressure phenotypes.;GAD

Disease

blood pressure;GAD

Disease

End- Stage Renal Disease (ESRD);GAD

Disease

Kidney disease;FunDO

Disease

Cirrhosis;FunDO

Disease

METABOLIC;GAD

Disease

bipolar affective disorder;GAD

Disease

menopause;GAD

Disease

diabetes, type 2;GAD

Disease

Hamman-Rich syndrome;FunDO

Disease

power sports performance;GAD

Disease

immunoglobin A nephropathy;GAD

Disease

Proteinuria;FunDO

Disease

preeclampsia;GAD

Disease

REPRODUCTION;GAD

Disease

CARDIOVASCULAR;GAD

Disease

Stroke;GAD

Disease

Abruptio Placentae;GAD

Disease

coronary atherosclerosis.;GAD

Disease

CANCER;GAD

Disease

Myocardial Infarction;GAD

Disease

angiotensinogen concentrations;GAD

Disease

hypertension, pregnancy induced;GAD

Disease

longevity;GAD

Disease

Growth retardation;FunDO

Disease

blood pressure, arterial;GAD

Disease

Hepatitis B;FunDO

Disease

nephropathy, diabetic;GAD

Disease

IGA glomerulonephritis;FunDO

Disease

coronary events;GAD

Disease

Lupus vulgaris;FunDO

Disease

Transient hypertension of pregnancy;FunDO

Disease

Obesity;FunDO

Disease

coronary heart disease;GAD

Disease

cardiomyopathy;GAD

Disease

Abruption placentae;FunDO

Disease

coronary atherosclerosis;GAD

Disease

dementia, vascular;GAD

Disease

carotid intimal-medial thickening;GAD

Disease

RENAL;GAD

External Links

Links to Entrez Gene

183

Links to all GeneRIF Items

183

Links to iHOP

183

Sequence Information

Nucleotide Sequence

>183 : length: 2587
ATCCCATGAGCGGGCAGCAGGGTCAGAAGTGGCCCCCGTGTTGCCTAAGCAAGACTCTCC
CCTGCCCTCTGCCCTCTGCACCTCCGGCCTGCATGTCCCTGTGGCCTCTTGGGGGTACAT
CTCCCGGGGCTGGGTCAGAAGGCCTGGGTGGTTGGCCTCAGGCTGTCACACACCTAGGGA
GATGCTCCCGTTTCTGGGAACCTTGGCCCCGACTCCTGCAAACTTCGGTAAATGTGTAAC
TCGACCCTGCACCGGCTCACTCTGTTCAGCAGTGAAACTCTGCATCGATCACTAAGACTT
CCTGGAAGAGGTCCCAGCGTGAGTGTCGCTTCTGGCATCTGTCCTTCTGGCCAGCCTGTG
GTCTGGCCAAGTGATGTAACCCTCCTCTCCAGCCTGTGCACAGGCAGCCTGGGAACAGCT
CCATCCCCACCCCTCAGCTATAAATAGGGCATCGTGACCCGGCCGGGGGAAGAAGCTGCC
GTTGTTCTGGGTACTACAGCAGAAGGGTATGCGGAAGCGAGCACCCCAGTCTGAGATGGC
TCCTGCCGGTGTGAGCCTGAGGGCCACCATCCTCTGCCTCCTGGCCTGGGCTGGCCTGGC
TGCAGGTGACCGGGTGTACATACACCCCTTCCACCTCGTCATCCACAATGAGAGTACCTG
TGAGCAGCTGGCAAAGGCCAATGCCGGGAAGCCCAAAGACCCCACCTTCATACCTGCTCC
AATTCAGGCCAAGACATCCCCTGTGGATGAAAAGGCCCTACAGGACCAGCTGGTGCTAGT
CGCTGCAAAACTTGACACCGAAGACAAGTTGAGGGCCGCAATGGTCGGGATGCTGGCCAA
CTTCTTGGGCTTCCGTATATATGGCATGCACAGTGAGCTATGGGGCGTGGTCCATGGGGC
CACCGTCCTCTCCCCAACGGCTGTCTTTGGCACCCTGGCCTCTCTCTATCTGGGAGCCTT
GGACCACACAGCTGACAGGCTACAGGCAATCCTGGGTGTTCCTTGGAAGGACAAGAACTG
CACCTCCCGGCTGGATGCGCACAAGGTCCTGTCTGCCCTGCAGGCTGTACAGGGCCTGCT
AGTGGCCCAGGGCAGGGCTGATAGCCAGGCCCAGCTGCTGCTGTCCACGGTGGTGGGCGT
GTTCACAGCCCCAGGCCTGCACCTGAAGCAGCCGTTTGTGCAGGGCCTGGCTCTCTATAC
CCCTGTGGTCCTCCCACGCTCTCTGGACTTCACAGAACTGGATGTTGCTGCTGAGAAGAT
TGACAGGTTCATGCAGGCTGTGACAGGATGGAAGACTGGCTGCTCCCTGATGGGAGCCAG
TGTGGACAGCACCCTGGCTTTCAACACCTACGTCCACTTCCAAGGGAAGATGAAGGGCTT
CTCCCTGCTGGCCGAGCCCCAGGAGTTCTGGGTGGACAACAGCACCTCAGTGTCTGTTCC
CATGCTCTCTGGCATGGGCACCTTCCAGCACTGGAGTGACATCCAGGACAACTTCTCGGT
GACTCAAGTGCCCTTCACTGAGAGCGCCTGCCTGCTGCTGATCCAGCCTCACTATGCCTC
TGACCTGGACAAGGTGGAGGGTCTCACTTTCCAGCAAAACTCCCTCAACTGGATGAAGAA
ACTATCTCCCCGGACCATCCACCTGACCATGCCCCAACTGGTGCTGCAAGGATCTTATGA
CCTGCAGGACCTGCTCGCCCAGGCTGAGCTGCCCGCCATTCTGCACACCGAGCTGAACCT
GCAAAAATTGAGCAATGACCGCATCAGGGTGGGGGAGGTGCTGAACAGCATTTTTTTTGA
GCTTGAAGCGGATGAGAGAGAGCCCACAGAGTCTACCCAACAGCTTAACAAGCCTGAGGT
CTTGGAGGTGACCCTGAACCGCCCATTCCTGTTTGCTGTGTATGATCAAAGCGCCACTGC
CCTGCACTTCCTGGGCCGCGTGGCCAACCCGCTGAGCACAGCATGAGGCCAGGGCCCCAG
AACACAGTGCCTGGCAAGGCCTCTGCCCCTGGCCTTTGAGGCAAAGGCCAGCAGCAGATA
ACAACCCCGGACAAATCAGCGATGTGTCACCCCCAGTCTCCCACCTTTTCTTCTAATGAG
TCGACTTTGAGCTGGAAAGCAGCCGTTTCTCCTTGGTCTAAGTGTGCTGCATGGAGTGAG
CAGTAGAAGCCTGCAGCGGCACAAATGCACCTCCCAGTTTGCTGGGTTTATTTTAGAGAA
TGGGGGTGGGGAGGCAAGAACCAGTGTTTAGCGCGGGACTACTGTTCCAAAAAGAATTCC
AACCGACCAGCTTGTTTGTGAAACAAAAAAGTGTTCCCTTTTCAAGTTGAGAACAAAAAT
TGGGTTTTAAAATTAAAGTATACATTTTTGCATTGCCTTCGGTTTGTATTTAGTGTCTTG
AATGTAAGAACATGACCTCCGTGTAGTGTCTGTAATACCTTAGTTTTTTCCACAGATGCT
TGTGATTTTTGAACAATACGTGAAAGATGCAAGCACCTGAATTTCTGTTTGAATGCGGAA
CCATAGCTGGTTATTTCTCCCTTGTGTTAGTAATAAACGTCTTGCCACAATAAGCCTCCA
AAAAAAA

Protein Sequence

>183 : length: 485
MRKRAPQSEMAPAGVSLRATILCLLAWAGLAAGDRVYIHPFHLVIHNESTCEQLAKANAG
KPKDPTFIPAPIQAKTSPVDEKALQDQLVLVAAKLDTEDKLRAAMVGMLANFLGFRIYGM
HSELWGVVHGATVLSPTAVFGTLASLYLGALDHTADRLQAILGVPWKDKNCTSRLDAHKV
LSALQAVQGLLVAQGRADSQAQLLLSTVVGVFTAPGLHLKQPFVQGLALYTPVVLPRSLD
FTELDVAAEKIDRFMQAVTGWKTGCSLMGASVDSTLAFNTYVHFQGKMKGFSLLAEPQEF
WVDNSTSVSVPMLSGMGTFQHWSDIQDNFSVTQVPFTESACLLLIQPHYASDLDKVEGLT
FQQNSLNWMKKLSPRTIHLTMPQLVLQGSYDLQDLLAQAELPAILHTELNLQKLSNDRIR
VGEVLNSIFFELEADEREPTESTQQLNKPEVLEVTLNRPFLFAVYDQSATALHFLGRVAN
PLSTA



')